Ensysce Biosciences Statistics
Total Valuation
ENSC has a market cap or net worth of $3.30 million. The enterprise value is $141,173.
| Market Cap | 3.30M |
| Enterprise Value | 141,173 |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, before market open.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ENSC has 7.59 million shares outstanding. The number of shares has increased by 440.17% in one year.
| Shares Outstanding | 7.59M |
| Shares Change (YoY) | +440.17% |
| Shares Change (QoQ) | +117.37% |
| Owned by Insiders (%) | 2.30% |
| Owned by Institutions (%) | 4.21% |
| Float | 7.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.88 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.87 |
| Quick Ratio | 2.14 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.21 |
Financial Efficiency
Return on equity (ROE) is -511.50% and return on invested capital (ROIC) is -250.31%.
| Return on Equity (ROE) | -511.50% |
| Return on Assets (ROA) | -266.10% |
| Return on Capital (ROIC) | -250.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.65M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.67% in the last 52 weeks. The beta is 0.85, so ENSC's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -79.67% |
| 50-Day Moving Average | 0.54 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 35.25 |
| Average Volume (20 Days) | 109,800 |
Short Selling Information
The latest short interest is 275,514, so 3.63% of the outstanding shares have been sold short.
| Short Interest | 275,514 |
| Short Previous Month | 264,821 |
| Short % of Shares Out | 3.63% |
| Short % of Float | 3.72% |
| Short Ratio (days to cover) | 1.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.00M |
| Pretax Income | -11.54M |
| Net Income | -11.55M |
| EBITDA | -9.94M |
| EBIT | -9.94M |
| Earnings Per Share (EPS) | -$3.77 |
Balance Sheet
The company has $3.40 million in cash and $245,973 in debt, giving a net cash position of $3.16 million or $0.42 per share.
| Cash & Cash Equivalents | 3.40M |
| Total Debt | 245,973 |
| Net Cash | 3.16M |
| Net Cash Per Share | $0.42 |
| Equity (Book Value) | 3.75M |
| Book Value Per Share | 0.49 |
| Working Capital | 3.06M |
Cash Flow
| Operating Cash Flow | -10.58M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.58M |
| FCF Per Share | -$1.86 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -440.17% |
| Shareholder Yield | -440.17% |
| Earnings Yield | -349.95% |
| FCF Yield | -320.69% |
Analyst Forecast
The average price target for ENSC is $7.00, which is 1,509.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 1,509.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 31, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Mar 31, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |